Claire is the sustainability and compliance lead at a mid-sized European food and beverage company, a role that's grown considerably in scope over the past two years as EU regulation has expanded into territory her job description never originally covered. Her CEO has asked her a version of the same question three times this quarter: are we actually ready for the deforestation regulation deadline, and if not, what exactly is still open. Each time, her honest answer has been some version of "mostly, I think" — which is not the kind of confidence a board wants to hear about a deadline carrying penalties that could reach four percent of the company's entire EU turnover.
Try it: EUDR/CSRD Supply-Chain Data Feed on the Apify Store →
The company sources cocoa and coffee for its product lines from a handful of countries, some with well-established supply chain documentation, others acquired through smaller regional distributors whose own record-keeping Claire has always privately worried about. Rather than continuing to answer "mostly, I think" a fourth time, she sits down with the company's full ingredient list and runs each relevant product through the EUDR/CSRD Supply-Chain Data Feed, checking commodity scope first.
The first useful thing the tool tells her is something she'd half-suspected but never confirmed with real precision: two of her twelve tracked ingredient lines, both classified under broader agricultural HS codes, actually fall outside the regulation's specific commodity scope entirely — not cocoa or coffee derivatives after all, despite internal assumptions that had lumped them in with the higher-risk category for the past year. That's not a dramatic discovery, but it's an immediately useful one: two fewer supply chains requiring the full due-diligence documentation her team had been quietly dreading having to build from scratch.
The remaining ten ingredient lines all confirm as in-scope, and here the tool's country-risk classification becomes the more interesting layer. Eight of her ten sourcing countries come back classified as standard risk — not the reassurance she was hoping for, but not the worst case either. Two, both smaller regional sourcing relationships acquired through distributors rather than direct supplier relationships, come back flagged as higher risk. That's the piece of information Claire actually needed months ago: a clear, prioritized list of exactly which two supply chains deserve the most urgent documentation effort, rather than a vague sense that the whole portfolio needs equal attention she doesn't have the resources to give.
She restructures her team's next quarter around that priority list. The eight standard-risk supply chains get a lighter-touch documentation review, confirming existing paperwork meets the baseline requirement. The two higher-risk relationships get real attention — direct conversations with the distributors involved, requests for more detailed sourcing documentation, and in one case, a serious internal conversation about whether that particular relationship is worth the compliance overhead relative to its business value.
The second piece of the tool that earns its place in her weekly routine is the regulatory-change monitoring, running in the background against her ingredient scope. Three weeks after her initial review, an alert surfaces: a minor amendment to implementation guidance, the kind of detail easy to miss in the broader flow of EU regulatory news but directly relevant to how her two flagged supply chains need to document compliance. She catches it the week it's published rather than discovering it secondhand, months later, from an industry newsletter or a supplier asking her a question she can't yet answer.
When her CEO asks the readiness question a fourth time, three months after that first ingredient review, Claire's answer has changed shape entirely. She's not saying "mostly, I think" anymore. She's saying: ten of twelve ingredient lines confirmed in scope, eight assessed as standard risk with documentation on track, two flagged as priority with active remediation underway, and a live monitoring process in place to catch any regulatory changes before they become a surprise. It's not a claim that everything is perfectly solved — two supply chains still need real work before the deadline arrives. But it's a genuinely different kind of answer, the difference between vague reassurance and a specific, evidence-backed status report a board can actually act on. For a role that's spent two years growing faster than the tools available to support it, that specificity is worth more than any amount of confident-sounding uncertainty ever was.